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Abstract
Background: Neonatal Staphylococcus aureus (S. aureus) bacteremia is an important cause of morbidity and
mortality. In this study, we examined whether methicillin-susceptible S. aureus (MSSA) transmission and genetic
makeup contribute to the occurrence of neonatal S. aureus bacteremia.
Methods: A retrospective, single-centre study was performed. All patients were included who suffered from S.
aureus bacteremia in the neonatal intensive care unit (NICU), Erasmus MC-Sophia, Rotterdam, the Netherlands,
between January 2011 and November 2017. Whole-genome sequencing (WGS) was used to characterize the S.
aureus isolates, as was also done in comparison to reference genomes. Transmission was considered likely in case
of genetically indistinguishable S. aureus isolates.
Results: Excluding coagulase-negative staphylococci (CoNS), S. aureus was the most common cause of neonatal
bacteremia. Twelve percent (n = 112) of all 926 positive blood cultures from neonates grew S. aureus. Based on core
genome multilocus sequence typing (cgMLST), 12 clusters of genetically indistinguishable MSSA isolates were
found, containing 33 isolates in total (2–4 isolates per cluster). In seven of these clusters, at least two of the
identified MSSA isolates were collected within a time period of one month. Six virulence genes were present in 98–
100% of all MSSA isolates. In comparison to S. aureus reference genomes, toxin genes encoding staphylococcal
enterotoxin A (sea) and toxic shock syndrome toxin 1 (tsst-1) were present more often in the genomes of
bacteremia isolates.
Conclusion: Transmission of MSSA is a contributing factor to the occurrence of S. aureus bacteremia in neonates.
Sea and tsst-1 might play a role in neonatal S. aureus bacteremia.
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Introduction
Staphylococcus aureus (S. aureus) is a well-established
nosocomial pathogen that causes multiple types of neo-
natal infections [1, 2]. Invasive S. aureus infections in ne-
onates (e.g. bacteremia) are common in very low birth
weight (VLBW) infants, which makes this bacterial spe-
cies one of the most important pathogens in neonatal in-
tensive care units (NICU) [3–5]. A significant risk factor
for S. aureus bacteremia in VLBW infants is the pres-
ence of intravascular catheters, which are frequently re-
quired [6–8]. In addition, S. aureus bacteremia can
result in severe complications such as endocarditis and
osteomyelitis [5, 9, 10]. All-cause mortality among neo-
nates suffering from S. aureus bacteremia varies between
10 and 20% [7, 11]. So there is an urgent need to prevent
this infection. To prevent S. aureus bacteremia in neo-
nates, it is important to know the factors contributing to
the high frequency and severity of this infection.
Previously, the virulence factors tsst-1 and sea were im-
plicated to play a role in S. aureus bacteremia [12–14].
Furthermore, transmission of S. aureus might contribute
to the high frequency of bacteremia. Outbreaks of
methicillin-resistant S. aureus (MRSA) at the NICU are
described and relatively easy to detect [15–18]. Mean-
while, the detection of methicillin-sensitive S. aureus
(MSSA) outbreaks seems to be more difficult, excluding
outbreaks in patients who suffer from a skin infection
[19–22]. In this study, whole-genome sequencing (WGS),
the typing method with the highest discriminatory power,
was used to determine whether MSSA transmission and
genetic makeup, contribute to the occurrence of neonatal
S. aureus bacteremia.
Methods
Population
The NICU of Erasmus MC-Sophia, Rotterdam, the
Netherlands, is a level IV, 27-beds facility. It is divided
into four units with six to eight beds each. Per year,
about 750 neonates are admitted. Nearly 40% of them
are below 32 weeks of gestation and were in majority
born in this hospital.
Screening
We included neonates with a presumed infection, of whom
blood cultures were obtained between January 2011 and
November 2017 that showed to be positive for S. aureus.
Clinical data concerning gender, gestational age, birth
weight and survival were obtained from patient records.
S. aureus isolates
Blood from neonates was cultured in BACTEC plus
PEDS aerobic bottles and incubated in the Bactec FX
(BD, Heidelberg, Germany). In case of positive blood
cultures, plates were inoculated and, after 16–24 h of
incubation at 37 °C, screened for S. aureus based on col-
ony morphology. Identification was performed by means
of a latex agglutination test (Slidex Staph Plus, bioMér-
ieux, Marcy-l’Etoile, France) and/or via matrix-assisted
laser desorption/ionisation, time-of-flight, mass spec-
trometry (MALDI-TOF MS system, Bruker). S. aureus
isolates were stored at − 20 °C or – 80 °C until use. The
VITEK 2 system (bioMérieux) was used for antimicro-
bial susceptibility testing (AST).
Whole-genome sequencing
Transmission
S. aureus isolates were processed according to the bio-
Mérieux EpiSeqcs V1 programme and sent to LGC Gen-
omics GmbH (Berlin, Germany) for next-generation
sequencing (NGS). We used Illumina chemistry, which
generated paired end 2 × 150 bp reads. Sequences were
assembled using the proprietary built-in assembler from
CLC Genomics Workbench v11 software (Qiagen,
Hilden, Germany) with default parameters. We analysed
them by means of the available S. aureus core genome
multilocus sequence typing scheme (cgMLST) [23] in
BioNumerics 7.6.3 (bioMérieux, Sint-Martens-Latem,
Belgium) which contains 1861 loci. Allele calling was
performed using two algorithms, one based on the as-
sembly using a BLAST approach (assembly-based call-
ing) and one based on the trimmed sequencing data
using a kmer based approach (assembly-free calling). A
consensus of both algorithms was used to assign final al-
lele calls: when both algorithms were in agreement or
when an allele call was made by only one of the algo-
rithms, the allele call was considered in the consensus.
However, when both algorithms were in disagreement,
the allele call was not considered in the consensus. Both
allele calling algorithms were executed using default pa-
rameters. Conventional MLST types were inferred in
silico from the WGS data. To this end, the seven MLST
loci were identified using the sequence extraction tool
and the MLST plugin from BioNumerics 7.6.3 that is
synchronized to the pubMLST.org public repository (ac-
cession date: April 5, 2019). For the visualisation of the
genetic relatedness between the isolates, we used a mini-
mum spanning tree for the cgMLST data. The MST was
generated using default parameters, and no re-sampling
was performed. Isolates containing less than 12 allelic
differences in the S. aureus core genome were consid-
ered genetically indistinguishable [23]. We defined a
cluster as more than two genetically indistinguishable
isolates and, within a cluster, considered transmission of
S. aureus likely. To further validate the results based on
the cgMLST approach, as additional method, we evalu-
ated transmission events using a SNP based approach
(Additional file 1: Table S1).
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Virulence
The presence of virulence genes was assessed, using the
sequence extraction tool in BioNumerics 7.6.3. Extrac-
tion parameters (percentage coverage and identity) were
individualised to accommodate for the different levels of
sequence diversity within and between the virulence
genes. Anticipating problems upon assembling virulence
genes containing repetitive motifs (sdrA, −B and -C, clfA
and –B, cna, sasG) using the short read sequence data,
only the largest non-repetitive part of these genes was
used for quering. In order to obtain data from a general
S. aureus population, the prevalence of virulence genes
was also assessed by means of the available genomic se-
quences in the Refseq Genome Database, using the
BLAST interface (https://blast.ncbi.nlm.nih.gov/Blast.
cgi). This database contained 10,288 S. aureus genomes
at the time of analysis. Virulence gene-specific search
parameters were used as discussed above. Role and func-
tion of the S. aureus virulence genes were described in
more detail earlier [12, 24]. An overview of analysed
virulence genes, their role, search parameters and query
sequence are shown in Additional file 2: Table S2.
Results
Patient characteristics
After coagulase-negative staphylococci (CoNS), MSSA
was the most frequent causative pathogen of bacteremia
in neonates. Several species of CoNS were isolated from
neonatal blood, but they were considered to be one
group. Twelve percent (n = 112) of 926 positive blood
cultures from neonates (one blood culture per episode
per patient), taken in the period January 2011 – Novem-
ber 2017, were positive for MSSA. Fifty-nine of the 112
neonates (52.7%) with MSSA bacteremia were male. The
median (interquartile range) for gestational age and birth
weight were 26 3/7 (25 1/7–30) weeks and 880 (680–
1150) grams, respectively. The onset of all episodes of
MSSA bacteremia occurred 72 h after birth, at a median
postnatal age of 10 (7–19) days. The overall mortality
among the included 112 patients was 20.5% while 11 of
these 23 neonates died of MSSA septicaemia.
Genetic relatedness
One hundred and four MSSA isolates from the total of 112
neonatal bloodstream isolates (93%) were available and
therefore included for WGS (including only the first isolate
per patient). Based on WGS, a total of 23 classical MLST
types were identified. The most predominant MLST types
were ST5 and ST45 (for both n = 16). For 11 MSSA isolates
a novel MLST type was found. To assess the genetic re-
latedness between the 104 isolates based on the more dis-
criminatory cgMLST scheme, we visualised the number of
allelic differences of the isolates in Fig. 1. Twelve cgMLST
clusters of genetically indistinguishable isolates were
observed, containing a total of 33 isolates (2–4 isolates per
cluster). In seven of these cgMLST clusters, at least two of
the identified MSSA isolates were collected within a time
period of one month. In two cgMLST clusters, all MSSA
isolates were found within a time period of one year, but
the shortest time interval between isolates of two neonates
was forty days. In the other three cgMLST clusters, there
was a time interval of more than one year between cultur-
ing the MSSA bloodstream isolates of two neonates. The
SNP approach confirmed our results based on the cgMLST
approach (Additional file 1: Table S1).
S. aureus virulence genes
An overview of virulence genes present in the 104 MSSA
isolates is provided in Table 1. Of the immunomodula-
tory proteins, staphylococcal complement inhibitor (scin)
was present in 100% of all bloodstream isolates. Alpha-
hemolysin (hla) was present in 99% of the isolates. We
also found a 98–100% presence of the MSCRAMMs
clumping factors A and B (clfA, clfB), immunodominant
surface antigen A (isaA) and iron-responsive surface de-
terminants A and H (isdA, isdH). When compared to a
reference population of S. aureus genomes, a few obser-
vations stand out. Remarkably, staphylococcal entero-
toxin A (sea) and toxic shock syndrome toxin 1 (tsst-1)
were, respectively, 2.6 and 3.2 times more prevalent
among the 104 neonatal bloodstream isolates, relative to
the reference genomes. Likewise, staphylococcal entero-
toxin h (seh) was 3.4 times more prevalent although, in
absolute numbers, this involved only a few isolates (6/
104 versus 173/10288). For the other virulence genes, no
such increases were detected (Table 1).
Discussion
At our level IV neonatal intensive care unit, as in many
centres [3–5], S. aureus is a frequent cause of neonatal
bacteremia. In our study, we explored the role of MSSA
transmission and the possible contribution of virulence
genes. By using WGS, 12 different cgMLST clusters of
MSSA isolates were found. Seven of these twelve
cgMLST clusters included at least two MSSA isolates,
cultured from blood of neonates within one month, indi-
cative for transmission. Transmission should therefore
be considered as a contributing factor for the frequent
occurrence of neonatal S. aureus bacteremia, as was re-
cently described by Rouard et al. [13]. Although it seems
reasonable to assume that transmission, irrespective of
the source, can only occur through the hands of health-
care workers (HCWs), we did not prove this, since we
did not culture the environment, nor the HCWs or par-
ents. Still, general measures such as improvement of the
current (daily) cleaning, disinfection procedures as well
as hand hygiene, will be likely to help. It was already
proven that neonatal hospital-acquired infections could
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in part be prevented by strict infection control measures
[8, 25, 26]. In addition, reinforcement of the implemen-
tation of central-line bundles has the potential to reduce
the incidence of central line-associated bloodstream in-
fections (CLABSIs); although these bundles are already
implemented, compliance can still be improved and add-
itional measures can be explored [27].
Besides transmission, it was determined whether the
presence of certain virulence factors is associated with
neonatal S. aureus bacteremia. Since it was difficult to
define a suitable control population of neonates, we chose
to compare neonatal S. aureus bacteremia isolates to all
available S. aureus genomes from the Refseq Genome
Database (N = 10,288 at the time of analysis). Remarkably,
the genes sea and tsst-1 were found a factor 2.6 and 3.2
times more often in the MSSA bloodstream isolates, com-
pared to the reference genomes in the Refseq Genome
Database. The overrepresentation of tsst-1 could not be
explained by the frequent presence of MLST ST5 and
ST45 in our isolates collection, since tsst-1 was not
Fig. 1 Minimum spanning tree, based on the core genome of 104 S. aureus isolates. Colours indicate the classical MLST sequence types (ST).
Twelve cgMLST clusters containing at least two isolates with a maximum of eleven allelic differences are indicated with a grey background
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associated with these sequence types. On the other hand,
11 of the 25 isolates carrying sea were found in ST5 iso-
lates. Still, this cannot be the full explanation for finding
an association between sea and neonatal MSSA
bacteremia. Many studies have been executed on S. aureus
toxins and their pathogenic roles, particularly on sea and
tsst-1. Previously, it was described that antibody responses
to these two specific toxins were higher in patients with S.
aureus bacteremia, compared to control patients [12]. In
addition, in a recent publication about a NICU MSSA
outbreak, tsst-1 and especially sea were found in blood-
stream isolates, compared to colonisation isolates [13].
Another review article describes the association of these
toxins with bacteremia [14]. Therefore, this may suggest
that sea and tsst-1 might play a role in the pathogenesis of
S. aureus bacteremia. The other virulence genes were
present in virtually all study isolates, but in virtually all ref-
erence genomes as well (Table 1).
Our study has its limitations. It was performed retro-
spectively, in a single centre. We considered less than 12
Table 1 Presence of virulence genes in neonatal S. aureus isolates compared to reference genomes
genes neonatal isolates (%) refseq (%) genes neonatal isolates (%) refseq (%)
sea 24.0 9.4 cna 51.0 34.6
seb 4.8 5.9 eap-map 64.4 93.7
sec 18.3 10.8 ebp 95.2 95.2
sed 10.6 8.8 fnbpA 66.3 75.2
seg 51.9 55.3 fnbpB 65.4 75.0
seh 5.8 1.7 sdrC 91.3 96.3
sei 55.8 55.2 sdrD 50.0 74.9
sej 10.6 11.1 sdrE 89.4 85.0
sek 3.8 19.0 efb 77.9 94.7
sel 18.3 10.8 icaA 100.0 97.8
sem 55.8 55.6 icaB 89.4 98.5
sen 45.2 55.2 icaC 99.0 97.8
seo 58.7 49.1 icaD 100.0 98.0
sep 4.8 19.1 icaR 95.2 97.7
seq 4.8 19.1 isaA 100.0 98.3
ser 10.6 10.9 isdA 100.0 97.6
ses 0.0 0.3 isdH 100.0 97.5
set 0.0 0.3 sasG 54.8 56.7
seu 51.9 54.8 edn 1.0 1.4
sey 1.0 5.8 etA 1.0 1.0
aur 100.0 98.2 etB 0.0 0.2
coa 70.2 83.0 etD 1.0 0.8
geh 87.5 97.5 hla 99.0 97.1
hysA 98.1 96.5 hlb 100.0 95.1
sak 73.1 78.5 hld 90.4 98.0
sspA 99.0 98.1 hlgA 96.2 97.6
sspB 91.3 98.1 hlgB 100.0 97.8
sspC 100.0 98.3 hlgC 98.1 97.5
vWbp 78.8 98.1 lukD 49.0 66.5
adsA 96.2 98.1 lukE 49.0 65.9
chp 68.3 67.2 lukF 0.0 18.8
sbi 100.0 97.7 lukM 0.0 0.7
scn 98.1 98.2 lukS 0.0 19.0
clfA 98.1 97.4 tsst-1 18.3 5.8
clfB 100.0 97.8
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allelic differences in the S. aureus core genome as indis-
tinguishable, as described by Leopold et al. for MRSA
outbreaks [23]. Still, it is a matter of debate which cut-
off should be used to define MSSA isolates as indistin-
guishable. If the cut-off would have been set at 20 alleles
[28], this would have led to 10 larger instead of 12 indis-
tinguishable MSSA clusters, which would not have chan-
ged the conclusion regarding transmission. Additional
studies are needed to define a clear cut-off. Finally, we
compared neonatal isolates to a large number of refer-
ence genomes, but these originate from several coun-
tries, several clinical sites and patients of all ages. It
would have been ideal if the reference genomes had
originated from colonized but not infected neonates, ad-
mitted to the same NICU, in the same time period.
Conclusions
In conclusion, transmission of MSSA seems a contribut-
ing factor to the occurrence of S. aureus bacteremia in
neonates. The possibility of MSSA transmission in neo-
natal intensive care should be explored to prevent this
invasive and serious infection. The exact role of sea and
tsst-1 warrants further investigation.
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